BSX — Boston Scientific Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual cashflow statement for Boston Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	4,700	-82	1,041	698	1,592
Depreciation
Deferred Taxes
Non-Cash Items	710	508	212	761	487
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-284	41	-351	-1,006	-771
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	1,836	1,508	1,871	1,526	2,503
Capital Expenditures	-610	-522	-554	-588	-711
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-4,431	111	-1,043	-1,423	-1,863
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-5,041	-411	-1,597	-2,011	-2,574
Financing Cash Flow Items	56	-206	-150	-464	-145
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	2,973	293	-95	-548	5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-222	1,388	173	-1,042	-70